Acute Interstitial Nephritis With Karyomegalic Epithelial Cells After Nivolumab Treatment—Two Case Reports

Clinical application of immune checkpoint inhibitors (CPIs) including nivolumab is expanding in the field of oncology treatment. Nivolumab is an anti-programmed death 1 protein (PD-1) antibody designed to augment an immunologic reaction against cancer cells. On the contrary, CPIs are known to cause...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clin Med Insights Case Rep
Hauptverfasser: Ryuzaki, Masaki, Tokuyama, Hirobumi, Uchiyama, Kiyotaka, Nakaya, Hideaki, Hasegawa, Kazuhiro, Miyashita, Kazutoshi, Konishi, Kohnosuke, Hashiguchi, Akinori, Wakino, Shu, Itoh, Hiroshi
Format: Artigo
Sprache:Inglês
Veröffentlicht: SAGE Publications 2019
Schlagworte:
Case Report
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6566467/
https://ncbi.nlm.nih.gov/pubmed/31223235
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1179547619853647
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge